Company / Income Tax
VYNE Therapeutics Inc. Income Tax History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$4.0K
FY2025
5-year range
-$448.0K / $13.0K
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Income Tax has fluctuated over the past 7 years, ranging from -$448,000 in FY2022 to $212,000 in FY2020.
Based on SEC 10-K filings.
$4,000 in FY2025 with a 5-year CAGR of -54.8%.
Improved from $13,000 to $4,000 over the past 2 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -54.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -54.8%, indicating a declining trend.
- Peak income tax was recorded in FY2020.
- Lowest income tax in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.0K | - |
| FY2024 | $0 | -100.0% |
| FY2023 | $13.0K | +102.9% |
| FY2022 | -$448.0K | -73.6% |
| FY2021 | -$258.0K | -221.7% |
| FY2020 | $212.0K | - |
| FY2019 | $0 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026